Chest pain is universally a leading cause of emergency department visits. Technological advancements have led to the development of high-sensitivity troponin assays. The application, interpretation, and appropriate utilization of their results is still under investigation. Furthermore, the increased sensitivity of these assays raises additional challenges such as determination of true myocardial infarction (MI) versus other causes of myocardial injury, appropriate timing of serial troponin sampling (i.e., from 1 to 6 hours), and prognostic implications of persistently elevated troponin levels. This study sought to develop a calculator capable of identifying the probability of acute MI (AMI) and 30-day outcomes, as well as provide prognostic information on patients identified as not having a myocardial infarction.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Emergency Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2019 Published by Elsevier Inc.